Literature DB >> 26190618

A case of adult-onset type II citrullinemia induced by hospital diet.

Akira Ueda1,2, Kazuhiko Okada2, Terumi Takahara3, Keiichi Iwasa2, Kazuko Shinagawa2, Akio Entani2, Syuji Inatsuchi2, Takayuki Ando1, Haruka Fujinami1, Kazuto Tajiri1, Yoshiharu Tokimitsu1, Kohei Ogawa1, Takayoshi Miyazono1, Takako Miyazaki1, Jun Murakami1, Ayumu Hosokawa1, Satoshi Yasumura1, Masami Minemura1, Takahiko Kudo1, Toshiro Sugiyama1.   

Abstract

A 47-year-old Japanese man was first admitted to our hospital for 8 days because of an asthma attack. After discharge he changed his diet. On the 12th day after his discharge, he was re-admitted to our hospital because he exhibited transient loss of consciousness with flapping tremor. His plasma ammonia level was extremely high (245 μg/dL; normal, <90 μg/dL), suggesting hepatic encephalopathy. He underwent intravenous administration of branched-chain amino acids (Aminoleban(®)) and oral administration of lactulose and kanamycin sulfate; however, the hyperammonemia did not improve. Analysis of the amino acids and citrin gene led to the diagnosis of adult-onset type II citrullinemia (CTLN2). Following this diagnosis, the carbohydrate content of his diet was mildly restricted. As a result, his plasma ammonia level markedly improved (ammonia, 40-60 μg/dL) and he became symptom-free without any medication. CTLN2 is a metabolic disorder characterized by increased plasma concentrations of citrulline and ammonia, which occurs by the failure of compensatory mechanisms associated with diet. Here, we report a case of a patient for whom a change in eating habits during his hospitalization disturbed his compensatory mechanism resulting in clinical CTLN2, which was reversed with an appropriate diet.

Entities:  

Keywords:  CTLN2; Citrin; Citrullinemia; Hepatic encephalopathy; Hyperammonemia; SLC25A13

Year:  2010        PMID: 26190618     DOI: 10.1007/s12328-010-0188-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  21 in total

1.  Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2).

Authors:  Masahide Yazaki; Yo-ichi Takei; Keiko Kobayashi; Takeyori Saheki; Shu-ichi Ikeda
Journal:  Intern Med       Date:  2005-03       Impact factor: 1.271

Review 2.  Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: a hypothesis.

Authors:  M Ghyczy; M Boros
Journal:  Br J Nutr       Date:  2001-04       Impact factor: 3.718

3.  Orthotopic liver transplantation for urea cycle enzyme deficiency.

Authors:  S Todo; T E Starzl; A Tzakis; K J Benkov; F Kalousek; T Saheki; K Tanikawa; W A Fenton
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

4.  A search for the primary abnormality in adult-onset type II citrullinemia.

Authors:  K Kobayashi; N Shaheen; R Kumashiro; K Tanikawa; W E O'Brien; A L Beaudet; T Saheki
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

5.  Recovery from marked altered consciousness in a patient with adult-onset type II citrullinemia diagnosed by DNA analysis and treated with a living related partial liver transplantation.

Authors:  Yasuhiro Takashima; Makoto Koide; Hideyuki Fukunaga; Masahide Iwai; Masaki Miura; Ryoji Yoneda; Tsuneo Fukuda; Keiko Kobayashi; Takeyori Saheki
Journal:  Intern Med       Date:  2002-07       Impact factor: 1.271

6.  Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease.

Authors:  Yasushi Imamura; Keiko Kobayashi; Toshihiko Shibatou; Sachiko Aburada; Kenji Tahara; Osamu Kubozono; Takeyori Saheki
Journal:  Hepatol Res       Date:  2003-05       Impact factor: 4.288

Review 7.  Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle.

Authors:  Takeyori Saheki; Keiko Kobayashi; Mikio Iijima; Masahisa Horiuchi; Laila Begum; Md Abdul Jalil; Meng Xian Li; Yao Bang Lu; Miharu Ushikai; Ayako Tabata; Mitsuaki Moriyama; Kwang-Jen Hsiao; Yanling Yang
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

8.  Hepatocellular carcinoma in a case of adult-onset type II citrullinemia.

Authors:  Naoki Hagiwara; Yoshiki Sekijima; Yo-ichi Takei; Shu-ichi Ikeda; Seiji Kawasaki; Keiko Kobayashi; Takeyori Saheki
Journal:  Intern Med       Date:  2003-10       Impact factor: 1.271

9.  Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency.

Authors:  Ayako Tabata; Jian-Sheng Sheng; Miharu Ushikai; Yuan-Zong Song; Hong-Zhi Gao; Yao-Bang Lu; Fumihiko Okumura; Mikio Iijima; Kozo Mutoh; Shosei Kishida; Takeyori Saheki; Keiko Kobayashi
Journal:  J Hum Genet       Date:  2008-04-05       Impact factor: 3.172

10.  Reduced carbohydrate intake in citrin-deficient subjects.

Authors:  T Saheki; K Kobayashi; M Terashi; T Ohura; Y Yanagawa; Y Okano; T Hattori; H Fujimoto; K Mutoh; Z Kizaki; A Inui
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.